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ABSTRACT
Introduction: Individuals with autism spectrum
disorder (ASD) have difficulties in communication and
social interaction resulting from atypical perceptual and
cognitive information processing, leading to an
accumulation of anxiety. Extreme overloading
experienced internally may not be externally visible.
Identifying stressful situations at an early stage may
avoid socially problematic behaviour from occurring,
such as self-injurious behaviour. Activation of the
autonomous nervous system (ANS) is involved in the
response to anxiety, which can be measured through
heart rate variability and skin conductance with the use
of portable devices, non-intrusively and pain-free.
Thus, developing innovative analysis of signal
perception and reaction is necessary, mainly for
non-communicative individuals with autism.
Methods and analysis: The protocol will take place
in real life (home and social environments). We aim
to associate modifications of the ANS with external
events that will be recorded in a synchronous manner
through a specific design (spy glasses with video/
audio recording). Four phases will be carried out on
ASD participants and aged-matched controls:
(1) 24-hour baseline pre-experiment (physical
activity, sleep), (2) 2 h in a real life situation,
(3) 30 min in a quiet environment, interrupted by a
few seconds of stressful sound, (4) an interview to
record feelings about events triggering anxiety. ASD
and control participants will be together for phases
2 and 3, revealing different physiological responses to
the same situations, and thus identifying potentially
problematic events. The novelty will be to apply
time-series analyses (which led to several Nobel
Prizes in quantitative finance) on ANS series (heart
rate, heart rate variability, skin conductance) and
wrist motion.
Ethics and dissemination: Ethical approval has
been obtained from Ethics Committee of Clermont-
Ferrand (South-East I), France (2014-A00611–46).
Trial findings will be disseminated via open-access
peer-reviewed publications, conferences, clinical
networks, public lectures and our websites.
Trial registration number: ClinicalTrials identifier
NCT02275455.
BACKGROUND
Autism spectrum disorder (ASD) is a set of
heterogeneous neurodevelopmental condi-
tions characterised by early-onset difficulties
in social interaction and communication,
with unusually restricted, repetitive behaviour
and interests.1 Constantly increasing, the
worldwide prevalence is reaching 1%.1 2
Even if genetics has a key role in its aetiology,
environmental factors in early development
are also influential.3
Atypical neural development4 commonly
underpins atypical cognitive profiles, such as
impaired social cognition and social percep-
tion, executive dysfunction, and atypical per-
ceptual and information processing.5 Most
individuals with autism suffer from psycho-
logical comorbidities such as social anxiety,
Strengths and limitations of this study
▪ ‘Do Well B.’ is a multidisciplinary project that
builds innovative links between autism spectrum
disorders (ASD), audiovisual signal processing,
physiological response, and stochastic modelling
and statistics.
▪ This study investigates the novel concept of
advancing a personal health system (PHS) for
early detection of challenging behaviours for
ASD individuals. Such a PHS could be easily and
daily used, outside the hospital. Moreover, early
comprehensive and targeted behavioural inter-
ventions could improve social communication
and reduce anxiety and aggression.
▪ We limited our project to modelling, experiments
and data processing. The deliverable objective is
numerical codes for early detection of autism
disorders. This may appear as a limitation, yet
our project seems reachable.
▪ Finally, we will disentangle different behaviours
such as anxiety, rest and physical activity. Thus,
this study has a huge potential in the field of
‘mobile e-Health solutions’.
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attention-deficit and oppositional defiant disorders.6
Social adapting behaviours decrease as symptoms due to
a dysfunction in sensory processing increase, through
the increase of anxiety.7 Individuals with autism often
experience states of emotional or cognitive overload.8
Measurements taken from home and school environ-
ments have shown that experiences of extreme overload-
ing internally may not be visible externally. For example,
an individual with ASD can have a resting heart rate
(HR) twice the level of non-autistic peers, while out-
wardly appearing calm and relaxed.8 Thus, tools to
measure internal anxiety are needed.
Activation of the autonomous nervous system (ANS) is
involved in response to stress and anxiety.9 The ANS is a
balance between sympathetic and parasympathetic activity.
When an individual is threatened, parasympathetic activity
is inhibited, triggering a series of responses to promote
survival (ie, increased HR and increased blood flow to the
limbs). By contrast, when the surrounding environment is
perceived as safe, the parasympathetic system is activated,
slowing the HR, promoting social behaviour and homeo-
static functions.10 Analysing ANS variations is important
for understanding and helping people with ASD because
ANS activation influences and is influenced by sensory
information, social interactions and physical activity.8 The
most common measures of ANS are HR variability (HRV)
and skin conductance (SC).
The balance between sympathetic and parasympa-
thetic activity can be assessed by measuring HRV.11 Low
HRV has been associated with anxiety12 and stress,9 and
HRV may provide a good tool to infer emotions.10
Moreover, individuals with autism exhibit less cardiac
capacity to adjust for demanding tasks,13 and also have
reduced cardiac parasympathetic activity.14 Conveniently,
HRV can be measured non-intrusively and pain-free.
The sympathetic nervous system, influenced by
changes in emotions, releases acetylcholine, which acts
on muscarine receptors, causing a subsequent burst of
sweat and increased SC.15 For individuals with ASD, SC
is augmented with stress,16 the ‘fight or flight’ response
activation,8 and is also related to cognitive arousal.17
Similar to HRV, SC can be measured with the use of a
portable device, non-intrusively and pain-free. Moreover,
SC reacts immediately and is not influenced by haemo-
dynamic variability or neuromuscular blockade.15
Early comprehensive and targeted behavioural inter-
ventions can improve social communication and reduce
anxiety and aggression.18 19 For individuals with ASD,
identifying stressful situations at an early stage may avoid
the occurrence of socially problematic behaviour, such
as self-injury. Most individuals with ASD suffer from
abnormal sensitivity experiences,20 particularly within
the acoustic environment,5 21 which may cause accumu-
lation of anxiety. Thus, developing innovative analysis of
signal perception and reaction is necessary,22 mainly for
non-communicative people with autism.
The primary hypothesis is that variations of HR time-
series will allow fast detection of anxiety before an
extreme overloading is experienced internally, even if
this overloading is yet to be visible externally. Moreover,
HR and HRV time-series will also detect an absence of
an expected reaction to a warning situation such as
crossing at the traffic lights.
The secondary hypothesis is that modifications of the
parameters of the SC time-series will also detect anxiety
before an extreme overloading; HR-series and SC-series
will detect different responses and may be complemen-
tary, as will other physiological responses such as wrist
motion or respiratory rate. We will use statistics for multi-
variate physiological time-series (HR, HRV, SC, wrist
motion, respiratory rate). HR responses, measured with
the use of an HR thin elasticised transmitter belt placed
on the chest, will be sufficient to compare with a Holter
ECG. Respiration rate, measured with the same HR
transmitter belt, will be helpful to detect anxiety.
Reactions of different body segments measured with an
accelerometer will also be helpful to distinguish anxiety
from physical activity.
Therefore, our aim will be to link the results from ana-
lysis of physiological time-series to environmental signals
to build a personal health system (PHS) for early detec-
tion of challenging behaviour in individuals with autism
in real life situations in a community setting.
METHODS
Trial design
We aimed to associate modifications of ANS (variations
of the HR and SC time-series) with external events. As
previously stated, individuals with ASD encounter diffi-
culties in social interactions and would also experience
challenges following any laboratory-based protocol.
Subsequently, we decided to conduct a study in real life
situations, outside the hospital or laboratory, in a
so-called ecological situation. Statistical calculations are
based on time-series analysis. First, we detect times of
change for the mean of HR series and high-frequency
(HF) as well as low-frequency (LF) energies. By doing
so, we obtain segments where the different physiological
series stay in a steady state. Next, we compute the mean
HR, HF and LF energies of HRV on each segment.
Then, these data are used for classifications to qualify
the thresholds of stress for individuals (see details in
section on statistics below).23
The study design permits the synchronous recording
of data from HR, SC, respiratory rate, wrist motion and
the contextual events. Responses to four phases will be
conducted during this research on ASD participants and
aged-matched controls: (1) 24 h pre-experimental
recording for baseline, (2) a 2 h experimental recording
in real life situations, (3) a 30 min recording in a quiet
environment, interrupted by a few seconds of stressful
sound, (4) within the realms of possibility, an interview
will be achieved with the participant to capture com-
ments and feelings about events triggering anxiety. Each
participant (ASD and control) will undergo phases 1 to 4,
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with the recording of data from HR, SC and contextual
events during phases 1 to 3. ASD participants will be
paired with their matched control during phases 2 and 3.
Thus, they will live the same situation at the same time,
allowing us to detect different responses between them
and identify potentially stressful situations for ASD
participants.
Participants
Inclusion criteria for participants with autism are:
▸ A reliable diagnosis of ASD, based on the autism
diagnostic interview—revised (ADI-R),24 and the
autism diagnostic observation schedule—generic
(ADOS-G).25 The Vineland adaptive behavior scales
(VABS)26 will measure personal and social skills of
participants.
▸ No change in medical prescription in the previous
3 months and during the experiment.
▸ Age between 10 and 25 years because, on the one
hand, we need to examine participants in a moder-
ately free situation and this will be more acceptable
for parents if the children are 10 or above; and on
the other hand, an absolutely reliable diagnosis of
ASD (established with ADI-R and ADOS international
tests) is hard to reach in those individuals aged over
25 years.
The same inclusion criteria will apply for the paired
individuals with the exception of ASD. The paired
control will be chosen among the friends of the individ-
ual with ASD. In cases of difficulties recruiting controls,
the psychologist adviser may serve as control.
Recruitment and study protocol will start on February
2015 and can continue to December 2015.
Outcomes
The primary objective will be to demonstrate that ana-
lysis of HR and HRV time-series obtained from a Holter
ECG recording will detect anxiety before an extreme
overloading experienced internally becomes visible
externally (figure 1).
Secondary objectives will be to demonstrate that:
▸ SC will detect anxiety before an extreme overloading
becomes visibly apparent;
▸ HRV and SC will detect different types of responses
but can also provide complementary information;
▸ HRV and SC will also detect the absence of reaction
to a warning situation, such as crossing at the traffic
lights;
▸ HRV measured with the use of an HR transmitter
belt placed on the chest will be sufficient compared
with a Holter ECG;
▸ Respiration rate measured with the use of an HR
transmitter belt placed on the chest will be helpful in
detecting anxiety;
▸ Movement of the body measured with an accelerom-
eter worn at the wrist will also be helpful in detecting
anxiety.
Intervention
A direct ‘medical’ environment (psychiatrist, psycho-
logical adviser, general practitioner or other significant
individual involved with the ASD participant) will be
included in this study and will have to agree to the par-
ticipation of the individual with ASD in our study.
In order to list the potentially problematic sounds and
situations, a 1 h interview will be conducted with parents
and, if possible, with efficient speaking participants. To
understand more about anxiety in their environment,
questions will be asked about individuals’ stressful situa-
tions and sounds, as well as related health issues such as
hearing capacity, medications, sleeping habits and per-
sonal interests.
More precisely, the four phases will consist of (table 1):
▸ Phase 1: A 24 h phase will be used to record HR and
SC during sleep to record baseline data. In addition,
a short period of 2 min of physical activity (riding a
stationary bicycle, or running or jumping) will be
used to check the sensitivity of HR responses as HR
should respond linearly to exercise stimuli, either
during resistance27 or endurance28 activity.
▸ Phase 2: Participants with ASD and their paired coun-
terpart will be exposed to a ‘real life situation’ over a
period of 2 h. Both will be exposed to the same situ-
ation simultaneously. This should reveal different
physiological responses (HR and SC data) to identical
situations, and to identify which sound events and
situations are potentially problematic. The ‘real life
situation’ will start with a 5 min baseline rest (ie,
sitting quietly with a familiar person) in order to later
Figure 1 In autism spectrum
disorders, accumulation of
anxiety experienced internally
may not be visible externally,
leading to socially problematic
behaviour. Detecting anxiety at
an early stage through analysis of
physiological signals, before
extreme anxiety overloading, may
avoid the occurrence of socially
problematic behaviour.
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interpret physiological reactivity, specifically HRV and
SC.
▸ Phase 3: ASD participants will be tested in a ‘sound
stressing situation’, that is, a situation where a ‘prob-
lematic’ sound will be produced after spending
15 min in a very quiet situation (at home when pos-
sible). For very obvious ethical reasons, the problem-
atic sound will be chosen among those that are
weakly stressful and easily produced in the family
environment (such as vacuum cleaner, doorbell or a
specific voice) for a standard period. Directly after
the sound exposure, physiological responses will be
recorded for another 15 min quiet period.
▸ Phase 4: At least for controls and high-functioning
ASD participants, a postexperimental interview will
be conducted, in which comments and feelings can
be expressed about events that triggered specific HR
or SC modifications. To make this phase easy (espe-
cially regarding recollection of the psychological
states), participants will be invited to watch some
parts of the video and audio recording of the event.
Data from this phase will be particularly useful to
focus on physiological responses recorded during
‘specific’ events.
▸ The entire protocol from the neuropsychological
evaluation to the end of phase 4 will be completed
within 7 days.
Material
Heart rate variability
A Holter ECG and an HR transmitter belt will both
measure HR data during phases 1 to 3:
▸ A two-lead cardiscope ONE electrocardiogram Holter
(Hasimed, Graz, Austria) with 24 h recording time, a
1024 Hz sampling rate and 1 µV amplitude resolution,
will be used.
▸ The Zephyr BioHarness BT (Zephyr Technology,
Annapolis, USA), a thin elasticised HR transmitter
belt placed on the chest, with 26 h recording
memory, will be able to detect HRs between a range
of 25 and 240 bpm, and respiratory rate within 3–70
breaths/min range. The aim will be to demonstrate
that this relative inexpensive and easy-to-use device is
sufficient to detect anxiety. The respiratory rate could
also be a useful tool to detect anxiety. In addition,
the Zephyr BioHarness BT also has the capacity to
estimate the trunk’s movements with a triaxial
accelerometer.
The HR data will first be examined according to the
recommendations of the European Society of
Cardiology and the North American Society (Task
Force).29 30 HR data will be explored simultaneously in
time and frequency domains.31 The methodology devel-
oped by our team will also be applied.23
SC and motion series
SC will be measured in micro Siemens with sampling
rates at 2, 4, 8, 16 and 32 Hz during phases 1 to 3. The
SC sensor (Q-Sensor-Affectiva, Massachusetts Institute of
Technology, USA) is set on a wristband and has a 24 h
battery life when logging. In addition, it will measure
wrist movements with a built in triaxial accelerometer.
Recording contextual events
During phase 2, a set of ‘spy glasses’ (Active Media
Concept, Paris, France) will be used to record simultan-
eously the physical and social environment from the par-
ticipant’s point of view. A camera and a microphone
compose the ‘spy glasses’. The photodetector is a
Complementary Metal Oxide Semiconductor (CMOS)
sensor 1/18 with 720×480 resolution, a view angle of
60°, and records at 30 frames per second. Data are
stored on a 32 GB MicroSDHC card allowing for
2 h15 min of recording time. For participants who
already wear corrective glasses, the camera and micro-
phone will be placed on their own glasses.
Statistics
General design
Experiments will be conducted with two paired partici-
pants: the person with ASD and his age-matched
Table 1 Trial design
Participants with autism (n=30) Age-matched controls (n=30)
A 1 h interview to characterise autism and potentially
stressful events
Phase 1 A 24 h pre-experimental recording for baseline (sleep,
physical activity)
A 24 h pre-experimental recording for baseline (sleep,
physical activity)
Phase 2 A 2 h experimental recording in a real life situation A 2 h experimental recording in a real life situation
Phase 3 15 min recording in a quiet environment, followed by a
few seconds of stressful sound, followed by 15 min
recording in a quiet environment
15 min recording in a quiet environment, followed by
a few seconds of stressful sound, followed by 15 min
recording in a quiet environment
Phase 4 Interview to get comments on feelings about events that
triggered anxiety
Interview to get comments on feelings about events that
triggered anxiety
In yellow: During the 2 h experimental recording in real life and the 30 min recording in a quiet environment interrupted by a few seconds of
stressful sound, the participant with autism and the age-matched control will be together, revealing different physiological responses to the
same situations.
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control. Our aim is to measure the difference in regula-
tion of physiological responses between the two partici-
pants, in order to build a PHS for the early detection of
challenging behaviour in ASD individuals outside the
hospital. We will process multivariate physiological time-
series (HR, HRV, SC, wrist motion, respiratory rate) in
order to build a stress index. We will first use time-series
segmentation in order to identify the segment boundary
points in each univariate time-series. Second, we will
compute the dynamical parameters associated with each
segment, that is, mean value, HF and LF energies, and
also fractal index. Third, we will use classification algo-
rithms on the parameters obtained in the second step in
order to obtain different classes corresponding to differ-
ent levels of stress. Eventually, we will obtain, for each
time, the level of stress, and will be able to compare it
across the environmental conditions.
Analyses for the primary outcome
From heartbeat data, we will compute three time-series:
RR-intervals (distance between two consecutive R-waves
on ECG), HF and LF energies. HF and LF energies will
be assessed with the use of wavelets that are strategically
localised in time and frequency,32 contrary to Fourier
analysis, which is not localised in time. Then, detection
of abrupt changes will allow segmentation of the three
time-series into shorter time series of a few minutes with
a constant mean of RR-intervals, and HF and LF ener-
gies, respectively.23 33–35 Moreover, we will also estimate
the persistence or antipersistence of RR-intervals
through a piecewise constant fractal index (‘the Hurst
index’)36 37 combining increment ratio statistics38 and
detection of abrupt changes.35 Eventually, after having
performed a Principal Component Analysis,39 we will dis-
entangle clusters of variables characterising different
behaviours of RR-intervals series such as anxiety, rest
and physical activity.40
Number of participants needed
Stress effects on HR or HRV are documented in the lit-
erature.9 For instance, stress resulting from computer
work induces a bilateral variation of HR of a magnitude
greater than 5 bpm, without a significant change on LF
energy, but a significant variation of HF energy.
Specifically, Hjortskov et al41 demonstrated that, during
stress periods, the log(HF) was 7.03, while at rest, the
log(HF) was 7.49. This variation is plainly confirmed by
others,29 who have shown that during night time, the
log(HF) was 5.8±0.1 (average value±SD), or HR was 60.8
±1.3 bpm, and during daytime the log(HF) was 5.2±0.2,
or HR was 78.3±2.5 bpm. These data allowed us to
compute the sample size for a unilateral test at level
α=0.05 for a change of log(HF) of approximately 0.3 log
ms2, meaning that we reach a power of 0.90 as soon as
the sample size exceeds 5, and for a change of 5 bpm we
also reach a power 0.90 as soon as the sample size
exceeds 5. Eventually, even if we can process each single
series as a time-series,23 we still need the occurrence of
an overloading experience, which can be estimated at
p=0.8 during phase 2. Thus, with a sample size of 15,
the probability of k overloading experience is given by
the binomial law B(n,p), and we get P(k>6)=0.996. More
precisely, for k=7, we get a power 0.95. We will enrol 30
ASD participants and 30 age-matched controls to have a
comfortable data set, allowing a huge rate of drop-outs.
Analyses for the secondary outcomes
We will mainly apply the same statistical treatment for
the analyses of SC-series, respiratory rate and body
motion. For instance, in a preliminary study, we have
found that the SC for a 15-year-old participant with ASD
in stressful conditions was greater than in normal resting
conditions (SC=3.65±0.15 μS vs SC=3.31±0.13 μS, respect-
ively). So, at level α=0.05, for a change of SC of size
greater than 0.30 μS and a sample size k=7, we still reach
a power 0.90.
Method taking into account missing, unused or invalid data
On each physiological series (HR, SC, respiratory rate,
motion), missing or aberrant data are common and will
be removed with the use of the preprocessing method.23
Then, data sets with more than 10% of aberrant or
missing data will be rejected.29 30
Measures to reduce or avoid bias
Participant de-identification will blind assessors of par-
ticipant status when processing data. Participants with
autism will be paired with an age-matched control. The
ANS will be measured through different devices.
Ethics and dissemination
‘Do Well B.’ is a multidisciplinary project. It involves
eminent specialists in each field: probabilists and statisti-
cians, autism scientists and neuroscientists, physiologists
and cardiologists, and audio and audio-visual signal pro-
cessing specialists. Implementation and conduct of the
study will be monitored by the project management
committee (authors) who have extensive experience in
research and conducting clinical trials in ASDs, mathem-
atics and engineering. Trial findings will be disseminated
via open-access peer-reviewed publications, conferences,
clinical networks, public lectures and our websites. The
trial findings will also be made available to participants.
Both collectively and for the participants, identifying
stressful situations at an early stage may avoid socially
problematic behaviour from occurring, and may permit
early comprehensive and targeted behavioural interven-
tions. We may determine unknown stressful events and,
thus, target appropriate therapies. For the participants,
our intervention may permit self-evaluation, giving them
the chance to better anticipate and adapt to stressful
situation on their own. This protocol may also inciden-
tally detect cardiac disorders. Such an event will be com-
municated to the caregivers or the participant himself in
the realm of possibility. Any abnormality discovered will
not be covered by promoter’s insurance (our
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observational study cannot lead to such an event) and
will be supported by health insurance.
DISCUSSION
The main aim of “Design of well-being monitoring systems
(Do Well B.)” (figure 2) is to use statistics of multivariate
physiological time-series to build PHSs for early detec-
tion of challenging behaviour for ASD individuals,
outside the hospital. Early comprehensive and targeted
behavioural interventions can improve social communi-
cation and reduce anxiety and risk of aggression.
The idea is simple and corresponds to useful and
awaited applications. Innovation lies in the potential for
early detection of anxiety in autism disorders, that is,
psychological health rather than physiological health. As
pointed out by the WHO: “Health is a state of complete
physical, mental, and social well-being and not merely
the absence of disease or infirmity.” We have observed
huge advances in biological, physiological and psycho-
logical data processing inside the hospital. However, pro-
cessing physiological signals outside the hospital is still
in its early stages. So, the connection between health
information and communication technology addresses a
new challenge. Outside the hospital, in so-called eco-
logical situations, we cannot use heavy devices such as
functional MRI. However, today’s technology allows the
continuous monitoring of physiological signals with
embedded devices (HR, SC, motion), so-called physio-
logical time-series. Time-series analysis has a long history
in econometrics and quantitative finance, which has led
to several Nobel prizes being won,42–45 but a shorter
history in health and medicine. Thus our challenge is to
deduce modification of psychological regulation from
the variation of such physiological signals. In ecological
situations, there is feedback from the environment that
can manifest in audio signals and audiovisual cues that
result in a physiological answer. Audio and audiovisual
signals are both continuous time random signals and
should be studied by stochastic modelling and ad hoc
statistics tools. We will use and improve stochastic model-
ling and statistics of physiological and environmental
signals. ‘Do Well B.’ is a multidisciplinary project that
builds innovative links between ASD, audiovisual signal
processing, physiological response, and stochastic model-
ling and statistics. The use of “mobile e-Health solutions
for disease management, based on multi-parametric
data including physiological measurements” is addressed
in the Information and Communication Technology
Work Program of the European Community.
Potential limitations
We limited our project to modelling, experiments and
data processing. The deliverable objective is numerical
codes for early detection of autism disorders. This may
appear as a limitation, yet our project seems reachable.
As a consequence, we should be able to build a PHS for
early detection of challenging behaviour in ASD indivi-
duals, outside a hospital setting. We will have the possi-
bility to deposit a licence and develop industrial
applications.
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